Public Employees for Environmental Responsibility v. Regan

District Court, District of Columbia

Public Employees for Environmental Responsibility v. Regan

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

PUBLIC EMPLOYEES FOR ENVIRONMENTAL RESPONSIBILITY, et al.,

Plaintiffs, v. Civil Action No. 24-2194 (JEB)

MICHAEL REGAN, et al.,

Defendants.

MEMORANDUM OPINION

Frustrated by an inert regulatory process and setbacks in other courts, Plaintiffs Public

Employees for Environmental Responsibility and Center for Environmental Health have brought

this citizen suit under the Toxic Substances Control Act against the Environmental Protection

Agency and its administrator, Michael Regan. At base, they seek to compel EPA to prohibit

fluorination practices that produce a class of carcinogenic chemicals known as per- and

polyfluoroalkyl substances (PFAS), which have been found in fluorinated plastic packaging

(think: pesticide containers, bleach bottles, gas cans) manufactured by Inhance Technologies

LLC.

The problem for PEER and CEH, however, is that after they filed this action, EPA

initiated — at Plaintiffs’ behest — a rulemaking to address the production of PFAS. In moving

to dismiss, Defendants argue that this development has mooted Plaintiffs’ primary request for

relief. They further contend that the Court lacks jurisdiction to adjudicate Plaintiffs’ additional

1 demand that EPA seek interim injunctive relief until such rule is effective. Inhance, meanwhile,

has filed a Motion to Intervene in the suit and, with it, a Motion to Dismiss for lack of standing.

Because the Court agrees with Defendants that they have fulfilled any nondiscretionary duties

under the TSCA, it will grant their Motion to Dismiss and deny as moot Inhance’s Motion to

Intervene.

I. Background

The relevant timeline for our narrative begins on March 29, 2023, the date by which

Plaintiffs allege EPA possessed “conclusive data” showing both that a certain PFAS known as

perfluorooctanoic acid (PFOA) is carcinogenic and that it lurks in the “tens of millions of plastic

containers fluorinated by Inhance” that populate the U.S. economy. See ECF No. 1 (Compl.),

¶ 8. Armed with this information, Plaintiffs argue, EPA was obligated by statute to take certain

actions to “prevent or reduce to a sufficient extent” the risk posed by PFOA (more on the basis of

such obligation later). See

15 U.S.C. § 2603

(f).

The agency did so, ordering Inhance in December 2023 either to eliminate PFOA and

other PFAS from its fluorination process or to temporarily halt production. See Compl., ¶ 11;

Inhance Techs., LLC v. EPA,

96 F.4th 888, 890

(5th Cir. 2024). EPA issued that order under its

authority to regulate “significant new uses” of specific categories of PFAS. See

40 C.F.R. § 721.10536

;

15 U.S.C. § 2604

. Inhance, however, had been using its PFAS-producing

fluorination process since 1983. See Inhance,

96 F.4th at 890

. The company thus challenged

EPA’s order, and, in March of this year, the Fifth Circuit vacated it, concluding that Inhance’s

fluorination process was not a “new” use within the meaning of the statute. See

id.

at 893–95.

Worried that this development left PFAS unregulated, on April 11, 2024, Plaintiffs and

other interested groups subsequently filed a petition asking EPA to initiate a rulemaking under

2

15 U.S.C. § 2605

to prohibit throughout the United States the manufacture and distribution of

three PFAS (including PFOA) formed during the fluorination of plastic containers. See ECF No.

14 (MTD) at 7. On July 10, the agency granted that petition, informing Plaintiffs that it would

“promptly commence an appropriate proceeding under” § 2605. See ECF No. 14-1 (Pet. Grant)

at 2. “As part of that proceeding,” EPA explained, it would first “request information” from the

public “to ensure that any risks associated with” the PFAS under consideration “are

appropriately evaluated and managed.” Id. at 3.

Plaintiffs, however, found EPA’s proposed course of action unacceptably sluggish. A

little over two weeks later, they filed this lawsuit against Defendants under the TSCA’s citizen-

suit provision. See Compl.; see also

15 U.S.C. § 2619

(a)(2) (authorizing suits against EPA

administrator by “any person”). In their first claim for relief, PEER and CEH ask the Court to

order EPA to “immediately propose a rule . . . prohibiting the production of PFOA during the

Inhance fluorination process.” Compl., ¶ 121. Their second claim asks for an order requiring

EPA to commence a suit against Inhance to prohibit the formation of PFOA during the

fluorination process or otherwise to “make its proposed rule . . . imposing such a ban

immediately effective upon publication in the Federal Register.”

Id., ¶ 133

.

Two months later, on September 30, 2024, EPA published in the Federal Register a

notice seeking public comment as part of its rulemaking to address the risks of PFAS production

during the fluorination of plastic containers. See Certain PFAS Risk Management Under the

TSCA; Request for Comment,

89 Fed. Reg. 79581

(Sept. 30, 2024). In particular, it sought

information regarding the “number, location, and uses of fluorinated containers in the United

States”; “alternatives to the fluorination process that generates PFAS”; and “measures to address

risk from [PFAS] formed during the fluorination of plastic containers.”

Id. at 79582

. Such

3 information, EPA indicated, would “inform the Agency’s path forward with respect to” a

rulemaking under § 2605. Id.

II. Legal Standard

Because the issues in this case straddle the occasionally murky boundary between lack of

subject-matter jurisdiction and failure to state a claim, the Court will lay out both standards.

To survive a motion to dismiss under Federal Rule of Civil Procedure 12(b)(1), a plaintiff

generally bears the burden of proving that the court has subject-matter jurisdiction to hear its

claims. See DaimlerChrysler Corp. v. Cuno,

547 U.S. 332

, 342 & n.3 (2006); Arpaio v. Obama,

797 F.3d 11, 19

(D.C. Cir. 2015). A court has an “affirmative obligation to ensure that it is

acting within the scope of its jurisdictional authority,” Grand Lodge of Fraternal Order of Police

v. Ashcroft,

185 F. Supp. 2d 9, 13

(D.D.C. 2001), which includes the obligation to consider

issues of mootness. See Mine Reclamation Corp. v. FERC,

30 F.3d 1519

, 1522 (D.C. Cir. 1994).

Unlike some other jurisdictional issues, however, the party asserting mootness — here, the

Government — bears the burden of establishing that the case is in fact moot. See Honeywell

Int’l, Inc. v. NRC,

628 F.3d 568, 576

(D.C. Cir. 2010). Additionally, unlike with a motion to

dismiss under Rule 12(b)(6), the court “may consider materials outside the pleadings in deciding

whether to grant a motion to dismiss for lack of jurisdiction.” Jerome Stevens Pharms., Inc. v.

FDA,

402 F.3d 1249, 1253

(D.C. Cir. 2005).

Rule 12(b)(6) permits dismissal of a complaint for failure to state a claim upon which

relief may be granted. In evaluating such a motion to dismiss, courts must “treat the complaint's

factual allegations as true . . . and must grant plaintiff the benefit of all inferences that can be

derived from the facts alleged.” Sparrow v. United Air Lines, Inc.,

216 F.3d 1111, 1113

(D.C.

Cir. 2000) (quotation marks and citations omitted). Although “detailed factual allegations” are

4 not necessary to withstand a Rule 12(b)(6) motion, Bell Atlantic Corp. v. Twombly,

550 U.S. 544, 555

(2007), “a complaint must contain sufficient factual matter, accepted as true, to ‘state a

claim to relief that is plausible on its face,’” Ashcroft v. Iqbal,

556 U.S. 662, 678

(2009) (quoting

Twombly,

550 U.S. at 570

) — that is, the facts alleged in the complaint “must be enough to raise

a right to relief above the speculative level.” Twombly,

550 U.S. at 555

.

III. Analysis

Congress enacted the TSCA in 1976 to limit the public-health risks posed by dangerous

chemicals. See

15 U.S.C. § 2601

et seq. As previewed, the statute contains a citizen-suit

provision, similar to those in other environmental statutes, that authorizes civil suits against

EPA’s administrator to compel him “to perform any act or duty under this chapter which is not

discretionary.”

Id.,

§ 2619(a)(2). A nondiscretionary duty arises when the statute “categorically

mandates that all specified action be taken by a date-certain deadline.” Env’t Def. Fund v.

Regan,

2024 WL 3887383

, at *7 (D.D.C. Aug. 20, 2024) (cleaned up) (quoting Sierra Club v.

Thomas,

828 F.2d 783, 791

(D.C. Cir. 1987), superseded in part by statute,

Pub. L. No. 101-549, § 707

(f),

104 Stat. 2399

, 2683 (1990), as recognized in Mexichem Specialty Resins, Inc. v. Env’t

Prot. Agency,

787 F.3d 544

, 553 n.6 (D.C. Cir. 2015)).

Plaintiffs contend that two such duties are at issue here. The first is the statute’s

instruction that EPA, within 180 days of receiving information that a chemical substance

“presents a significant risk of serious or widespread harm to human beings,” “shall . . . initiate

applicable action under section 2604, 2605, or 2606 of this title to prevent or reduce to a

sufficient extent such risk” or otherwise determine that the risk is not unreasonable. See

15 U.S.C. § 2603

(f). After the Fifth Circuit’s ruling took § 2604’s significant-new-use order off the

table, Plaintiffs argue, EPA’s primary remaining option for complying with this duty was a

5 general rulemaking under § 2605. See ECF No. 23 (Opp.) at 20–22. Alternatively, Plaintiffs

contend in their second claim that if EPA fails to promulgate such a rule and make it

immediately effective, it faces an independent nondiscretionary duty to initiate a civil action for

injunctive relief against Inhance under § 2606. See id. at 26–30.

Defendants retort that the September 30 request for public comment posted in the Federal

Register mooted Plaintiffs’ first claim by initiating “applicable action” — i.e., a rulemaking

under § 2605. See MTD at 10–13; ECF No. 26 (Reply) at 5–9. They further argue that § 2606

does not impose a nondiscretionary duty on EPA and that, even it did, such relief cannot be

sought until a rule is promulgated without immediate effect — which has not happened here.

See Reply at 9–13.

The Court will address each claim in turn.

A. Claim One

Article III of the Constitution limits federal courts’ jurisdiction to “actual, ongoing

controversies.” Honig v. Doe,

484 U.S. 305, 317

(1988). Two interrelated doctrines — standing

and mootness — give life to this requirement. While standing probes “the plaintiff’s ‘concrete

stake’ at the outset of the litigation, mootness depends on whether the parties maintain a

‘continuing interest’ in the litigation today.” Hardaway v. Dist. of Columbia Housing Auth.,

843 F.3d 973, 979

(D.C. Cir. 2016) (citation omitted). For that reason, “mootness must be assessed

at ‘all stages’ of the litigation to ensure a live controversy remains.” Aref v. Lynch,

833 F.3d 242, 250

(D.C. Cir. 2016) (citation omitted). Courts must thus determine whether “events have

so transpired” such that a judicial “decision will neither presently affect the parties’ rights nor

have a more-than-speculative chance of affecting them in the future.” Am. Bar Ass’n v. FTC,

636 F.3d 641, 645

(D.C. Cir. 2011) (citation omitted). If “intervening events make it impossible

6 to grant the prevailing party effective relief,” no live controversy remains. Lemon v. Geren,

514 F.3d 1312, 1315

(D.C. Cir. 2008) (citation omitted). Put differently then, if “the parties lack a

legally cognizable interest in the outcome,” the case is moot and the court must dismiss for lack

of jurisdiction. Already, LLC v. Nike, Inc.,

568 U.S. 85, 91

(2013) (quoting Murphy v. Hunt,

455 U.S. 478, 481

(1982)); see Cierco v. Mnuchin,

857 F.3d 407, 414

(D.C. Cir. 2017).

It is no doubt true that, once the agency was in possession of information showing that

PFOA “presents a significant risk of serious or widespread harm to human beings,” it faced a

nondiscretionary duty to “initiate applicable action under section 2604, 2605, or 2606” within

180 days. See

15 U.S.C. § 2603

(f). Taking Plaintiffs’ allegations as true, EPA’s § 2603(f) duty

thus arose by March 29, 2023 — which means that it was tardy in issuing its initial order against

Inhance (in December 2023) and similarly dragged its feet after the Fifth Circuit vacated its

order, thus galvanizing Plaintiffs to file this action last July.

Defendants assert that the agency has now fulfilled that duty by posting its September 30,

2024, notice in the Federal Register to begin the process of “proposing and promulgating [a]

rule[] under” § 2605. See 89 Fed. Reg. at 79582. As they explain, the publication of that notice

“initiate[d] applicable action” under § 2603(f), thereby fulfilling EPA’s nondiscretionary duty

and extinguishing Plaintiffs’ “legally cognizable interest” in bringing the citizen suit. Already,

LLC,

568 U.S. at 91

; see Reply at 6–8.

Plaintiffs resist this conclusion, arguing that § 2603(f)’s requirement to initiate applicable

action here “plainly” requires “more than collecting information.” Opp. at 20–21. Instead, they

argue, it requires the immediate proposal of a rule addressing the public-health risk of PFAS

from fluorinated plastic. See id. at 21. In support, they point out that the generous 180-day time

limit “would have been unnecessary” if EPA could discharge its obligation merely by posting a

7 request for information. Id. They further maintain, with the support of an appended affidavit,

that EPA “already knows the answers” to the questions it posed in its notice and should proceed

directly to promulgating a rule. Id. at 23; see ECF No. 23-2 (Decl. of Kyla Bennett).

These arguments, however, impermissibly seek to expand the narrow opening created by

the citizen-suit provision. EPA’s sole nondiscretionary duty in § 2603(f) is to “initiate applicable

action” under one of three provisions. To do so under § 2605 (the rulemaking option), as the

Government points out, the agency must begin to undertake certain steps unique to that

provision, such as the preparation of a “[s]tatement of effects” that considers, among other

things, “the reasonably ascertainable economic consequences of the rule.”

15 U.S.C. § 2605

(c)(2)(A)(iv). EPA’s request for information here was explicitly designed to “inform the

Agency’s . . . regulation of” the relevant PFAS “under [§ 2605].” 89 Fed. Reg. at 79582. That

request plainly “initiate[d] . . . action,”

15 U.S.C. § 2603

(f), under § 2605 by kickstarting the

information-gathering process, and it therefore successfully completed the necessary first step of

any rulemaking. Plaintiffs’ preferred remedy would thus contravene the statute’s own

requirements, all in the service of inappropriately “embroil[ing] the Court in an assessment of the

substance of EPA’s actions or omissions.” Serra Club v. Browner,

130 F. Supp. 2d 78, 90

(D.D.C. 2001). And they cite no authority for their claim that the agency could rely on the

information it already gathered and published for its now-vacated § 2604 order to inform its

current § 2605 rulemaking, especially in light of the different “procedural and substantive

requirements” between the two sections. See Reply at 6 (noting that § 2604 orders “are specific

to the company” in question, while § 2605 rules are “broader” and separately require considering

impact of rulemaking on economy).

8 Nor does it matter here that Plaintiffs had previously petitioned for this rulemaking on

April 11, 2024, under a separate section of the TSCA. See

15 U.S.C. § 2620

(a) (“Any person

may petition the Administrator to initiate a proceeding for the issuance, amendment, or repeal of

a rule under section 2603, 2605, or 2607 of this title.”). As Defendants explain, that petition was

granted in full in the July 10, 2024, letter sent to Plaintiffs and their environmental allies. See

Pet. Grant. The letter indicated that the agency subsequently planned to “commence an

appropriate proceeding under” § 2605, beginning with a request for information. Id. at 3. That

Plaintiffs subsequently filed a citizen suit seeking to compel EPA to do just that — except faster

— does not entitle them to any additional relief under the statute. Rather, the initiation of the

rulemaking process under § 2605 serves the dual role of implementing the grant of the § 2620

rulemaking petition while also fulfilling EPA’s nondiscretionary duty under § 2603(f).

The September 30 publication thus rendered moot Plaintiffs’ first claim for relief, for

which the only available remedy would have been a court order requiring EPA to “initiate

applicable action” under that section. Cf. Ctr. for Env’t Health v. Regan,

103 F.4th 1027, 1038

(4th Cir. 2024) (where statutory language requires EPA only to “initiate a proceeding for the

issuance of a rule or an order,” “all the district court can provide . . . is an order directing the

EPA to initiate a proceeding for a rule or order”) (emphasis omitted). To the extent that

Plaintiffs’ prayer for relief asks for more, it goes beyond the TSCA’s limited language and thus

fails to state a claim for relief. See Givens v. Bowser,

111 F.4th 117

, 121–22 (D.C. Cir. 2024)

(argument that different statute does not permit requested relief “is a merits question, not a

jurisdictional question”). In either event, it must be dismissed.

9 B. Claim Two

The basis for Plaintiffs’ second claim is slightly more opaque. As previously noted, they

assert that EPA has a nondiscretionary duty to initiate a suit for injunctive relief against Inhance

under § 2606, which authorizes the agency to commence civil actions to seize “imminently

hazardous” chemical substances and enjoin manufacturing or distributing such substances. See

15 U.S.C. § 2606

(a)(1). To the extent that Plaintiffs believe this duty arises from § 2603(f), it

was fulfilled when EPA initiated the rulemaking under § 2605. That is because the statute

plainly leaves to the agency’s discretion the choice of how to satisfy its nondiscretionary duty, as

long as it “initiate[s] applicable action under section 2604, 2605, or 2606.”

15 U.S.C. § 2603

(f)

(emphasis added); cf. Campos-Chaves v. Garland,

144 S. Ct. 1637

, 1647 (2024) (“The word ‘or’

is almost always disjunctive and is generally used to indicate an alternative.”) (cleaned up).

Plaintiffs also argue, however, that such duty arises from § 2606 itself. To get there, they

rely on the provision’s instruction that EPA “shall” initiate a civil suit to address an imminently

hazardous chemical substance “[i]f the Administrator has not made a rule under section 2605(a)

of this title immediately effective.”

15 U.S.C. § 2606

(a)(2). On Plaintiffs’ telling, if an

imminently hazardous chemical substance is known to exist, and EPA has not yet promulgated a

rule to address it, it is obligated to bring suit under § 2606. See Opp. at 26–28.

This argument stumbles off the starting block. Even assuming that the provision

establishes a nondiscretionary duty — which the Court doubts, given the lack of a deadline that

is “date-certain” or “readily-ascertainable by reference to some other fixed date or event,”

Thomas, 828 F.2d at 790–91 — the apparent textual predicate of such an obligation is the

existence of a § 2605 rule in the first place. Only then, and only once such a rule had not been

10 made “immediately effective,” could any duty arise under § 2606. Absent a rulemaking, there is

nothing to be made “immediately effective” and consequently no obligation under § 2606(a)(2).

Plaintiffs protest that such a construction is “bizarre,” allowing suit when a “rulemaking

is already underway but not where [EPA] has taken no action at all against the imminent

hazard.” Opp. at 27. Whether or not that is so, it is the clear command of the statutory language,

which the Court is bound to follow. See Fourstar v. Garden City Grp. Inc.,

875 F.3d 1147, 1152

(D.C. Cir. 2017) (“It is not a judge’s job to add to or otherwise re-mold statutory text to try to

meet a statute’s perceived policy objectives. Instead, we must apply the statute as written.”).

Besides, it is Plaintiffs’ construction that corrodes the statutory scheme. Their

interpretation would require EPA to file suit under § 2606(a)(2) any time it finds an imminent

hazard, so long as no rule had yet been promulgated to address it. But subsection (a)(1) of that

provision vests the agency with discretion over the filing of such suits generally, stating that the

administrator “may” do so “notwithstanding” the existence of any other rule or order. See

15 U.S.C. § 2606

(a)(1). The regulatory paradigm thus appears to be one that broadly leaves to EPA

the decision of whether to file an imminent-hazard suit in any given instance, subject to the more

limited injunction in (a)(2) that the administrator “shall” do so whenever a rule promulgated to

address the specific hazard has not been made “immediately effective.” See, e.g., United States

v. Com. Edison Co.,

620 F. Supp. 1404, 1411

(N.D. Ill. 1985) (“Section 2606 permits the

government to close regulatory loopholes by taking action against applications of toxic

chemicals whose health and environmental risks are not sufficiently minimized by the regulatory

scheme.”) (emphasis added).

If the Court were to adopt Plaintiffs’ construction, however, EPA would be required to

file an imminent-hazard suit in all circumstances except when it already has a rule in effect

11 addressing the specific hazard. Subsection (a)(2)’s mandatory-suit requirement would then

become the default, confining (a)(1)’s discretion only to limited circumstances. Plaintiffs have

supplied little reason to read the statute in that manner. Congress, moreover, may have had good

reasons for preferring otherwise: Defendant’s interpretation ensures, for instance, that dramatic

interventions such as requesting the court-ordered seizure of property or halting of industrial

production are left to the agency’s discretion and will become mandatory only once EPA has

completed the careful consideration required by the statute’s rulemaking provisions.

Plaintiffs’ second claim therefore falls outside the terms of the TSCA’s citizen-suit

provision. Because that provision “constitutes a limited waiver of the federal government’s

sovereign immunity,” Physicians Comm. for Responsible Med. v. Horinko,

285 F. Supp. 2d 430, 441

(S.D.N.Y. 2003); see Basel Action Network v. Maritime Admin.,

370 F. Supp. 2d 57

, 75–76

(D.D.C. 2005), the claim must be dismissed for lack of subject-matter jurisdiction. Cf. Sierra

Club v. Wheeler,

956 F.3d 612, 616

(D.C. Cir. 2020) (construing as jurisdictional essentially

identical citizen-suit provision in Clean Air Act). Even were that not so, however, see Ctr. for

Env’t Health v. Inhance Tech. USA,

2023 WL 2808710

, at *2 (D.D.C. Apr. 6, 2023) (noting

D.C. Circuit has yet to weigh in on whether separate provision of § 2619 is jurisdictional),

Plaintiffs have, at a minimum, failed to state a claim under the statute.

IV. Conclusion

For the foregoing reasons, the Court will grant Defendants’ Motion to Dismiss and deny

as moot Inhance’s Motion to Intervene. A separate Order so stating will issue this day.

/s/ James E. Boasberg JAMES E. BOASBERG Chief Judge Date: December 11, 2024

12

Reference

Status
Published